scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 07, 2025 Generated net FUROSCIX(R) revenue of $16 million in the second quarter of 2025; up 99% over Q2 2024 Doses shipped to patients increased 45% over Q1 2025 and 117% over Q2 2024 Launch of FUROSCIX in chronic kidney disease […]
AGNC Investment Corp. (Nasdaq: AGNC) announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for August 2025. The dividend is payable on September 10, 2025 to common stockholders of record as of August 29, 2025. For further information or questions, please contact Investor Relations at
European and FDA approval of Sephience™ (sepiapterin) with broad labeling for PKU – Global launch underway in Europe and U.S. – Total Q2 Revenue of $179M – PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced a corporate update and financial results for the second quarter ended June 30, 2025. “We had another strong quarter highlighted by
FISERV INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fiserv, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – FI GlobeNewswire August 07, 2025 SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of
Secondquarter revenue of$1.043 billion, up 7% year-over-year and up 6% when adjusted for foreign exchange* Cloud Infrastructure Services** revenue of $71 million, up 30% year-over-year and up 29% when adjusted for foreign exchange* GAAP net income per diluted share of $0.71, down 17% year-over-year and down 18% when adjusted for foreign exchange*, and non-GAAP net
Thirty-Eighth Consecutive Period of Record Revenue AudioEye, Inc.(Nasdaq: AEYE) (“AudioEye” or the “Company”), the industry-leading digital accessibility company,reported financial results for the second quarter ended June 30, 2025. https://mma.prnewswire.com/media/1470477/AudioEye_v3_Logo.jpg “We achieved our 38th sequential quarter of growth, a remarkable achievement. We expect annualized sequential revenue growth in the high teens in the second half, driven
$1.86B of Cloud Revenues, 2.0% Y/Y growth Announces 5% increase of dividend New $300 million share repurchase program Fiscal 2025 Annual Highlights Y/Y (in millions)(1)Total Cloud Profitability EPS Cash FlowsRevenues Revenues Net Income A-EBITDA GAAP Non-GAAP Operating Free Cash Flows$5,168 $1,856 $436 $1,784 $1.65 $3.82 $831 $687-10.4% Y/Y 2.0% Y/Y 8.4% margin 34.5% margin -3.5%
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025 GlobeNewswire August 07, 2025 $60.0M in 2Q25 Total Product Revenue More than 100 Patients Treated with Amtagvi(R) in 2Q25 Strategic Restructuring Extends Cash Runway into 4Q26 FY25 Total Product Revenue Guidance of $250M-$300M Reiterated SAN CARLOS, Calif., Aug. 07, 2025
ThreeSixty Journalism Concludes 2025 Storytelling Institute for Local Students Future journalists explored topics of addiction and recovery in collaboration with Blue Cross and Blue Shield of Minnesota and Minnesota media GlobeNewswire August 07, 2025 ST. PAUL, Minn., Aug. 07, 2025 (GLOBE NEWSWIRE) — ThreeSixty Journalism has successfully concluded its 2025 Multimedia Storytelling Institute, a three-week
ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) — EXP, a global engineering, architecture, design and consulting firm, recently established a new infrastructure sector led by business development leader and Senior Vice President Kyle Henry. The new sector, Expansion, enhances EXP's capabilities in delivering complex infrastructure projects and strengthens EXP's presence in aviation, transit and civil infrastructure